Cell Therapy News/Articles, page-17995

https://www.painnewsnetwork.org/stories/2024/7/25/fda-approves-study-of-stem-cell-injection-for-degenerative-disc-disease#google_vignette

Apologies if this has been posted before. A 400 patient trial for DDD:

"IDCT has been granted regenerative medicine advanced therapy and Fast Track designations by the FDA. Approval of the Phase 3 study came just weeks after Discgenics released positive results from a combined Phase 1/Phase 2 human trial of IDCT, published in the International Journal of Spine Surgery."

Not only does it have relavancy of course for MSB, Mesoblast is actually mentioned in the article:

"Mesoblast, an Australian company specializing in regenerative medicine, recently began enrolling U.S. patients with chronic low back pain in a Phase 3 study of its proprietary mesenchymal stem cells, which are derived from young and healthy adult donors,"